WO1998045442A3 - Secreted f-spondin homologs - Google Patents
Secreted f-spondin homologs Download PDFInfo
- Publication number
- WO1998045442A3 WO1998045442A3 PCT/US1998/007117 US9807117W WO9845442A3 WO 1998045442 A3 WO1998045442 A3 WO 1998045442A3 US 9807117 W US9807117 W US 9807117W WO 9845442 A3 WO9845442 A3 WO 9845442A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- secreted
- zsig25
- spondin
- homologs
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU69613/98A AU6961398A (en) | 1997-04-10 | 1998-04-10 | Secreted f-spondin homologs |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4342197P | 1997-04-10 | 1997-04-10 | |
US60/043,421 | 1997-04-10 | ||
US4928897P | 1997-06-11 | 1997-06-11 | |
US60/049,288 | 1997-06-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998045442A2 WO1998045442A2 (en) | 1998-10-15 |
WO1998045442A3 true WO1998045442A3 (en) | 1999-01-14 |
Family
ID=26720414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/007117 WO1998045442A2 (en) | 1997-04-10 | 1998-04-10 | Secreted f-spondin homologs |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6961398A (en) |
WO (1) | WO1998045442A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1251139A3 (en) * | 1998-04-08 | 2002-12-18 | Genentech, Inc. | Human mindin-like protein and nucleic acids encoding it |
CA2347085A1 (en) * | 1998-10-19 | 2000-04-27 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US6960433B1 (en) | 1998-10-19 | 2005-11-01 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
EP1466977A1 (en) * | 1999-03-08 | 2004-10-13 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
US6682902B2 (en) | 1999-12-16 | 2004-01-27 | Schering Aktiengesellschaft | DNA encoding a novel RG1 polypeptide |
DE10050274A1 (en) * | 2000-10-09 | 2002-04-18 | Henkel Kgaa | In vitro assays for skin stress and skin ageing includes determination of spondin 2, cathepsin L, actin gamma 1 and vimentin fragments secreted by skin fibroblasts |
CA2532394C (en) | 2003-07-22 | 2013-09-17 | Schering Aktiengesellschaft | Rg1 antibodies and uses thereof |
US7294704B2 (en) * | 2003-08-15 | 2007-11-13 | Diadexus, Inc. | Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020196A1 (en) * | 1992-04-02 | 1993-10-14 | The Trustees Of Columbia University In The City Of New York | Cloning, expression and uses of a novel secreted protein, f-spondin |
WO1997029189A1 (en) * | 1996-02-12 | 1997-08-14 | Human Genome Sciences, Inc. | Human neuronal attachment factor-1 |
-
1998
- 1998-04-10 AU AU69613/98A patent/AU6961398A/en not_active Abandoned
- 1998-04-10 WO PCT/US1998/007117 patent/WO1998045442A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993020196A1 (en) * | 1992-04-02 | 1993-10-14 | The Trustees Of Columbia University In The City Of New York | Cloning, expression and uses of a novel secreted protein, f-spondin |
WO1997029189A1 (en) * | 1996-02-12 | 1997-08-14 | Human Genome Sciences, Inc. | Human neuronal attachment factor-1 |
Non-Patent Citations (1)
Title |
---|
GOBRON S ET AL: "SCO- spondin: a new member of the thrombospondin family secreted by the subcommissural organ is a candidate in the modulation of neuronal aggregation.", JOURNAL OF CELL SCIENCE, vol. 109, no. 5, May 1996 (1996-05-01), pages 1053 - 1061, XP002059006 * |
Also Published As
Publication number | Publication date |
---|---|
AU6961398A (en) | 1998-10-30 |
WO1998045442A2 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW428026B (en) | Bifunctional protein, preparation and use | |
EP1082433A4 (en) | Interleukins-21 and 22 | |
NZ332566A (en) | Antigen binding fragments that specifically detect cancer cells | |
AU6451798A (en) | Prostate cancer-specific marker | |
WO2001000666A3 (en) | Self-aligning peptides derived from human elastin and other fibrous proteins | |
IL132496A0 (en) | Mammalian cytokine-like factor 7 | |
WO1998005685A3 (en) | Self-aligning peptides derived from elastin and other fibrous proteins | |
WO1999030157A3 (en) | Neuropilins in methods for diagnosis and prognosis of cancer | |
WO2000005367A3 (en) | Human proteins having hydrophobic domains and dnas encoding these proteins | |
EP0825260A3 (en) | Arginase II | |
WO1999062942A3 (en) | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer | |
WO2001055411A3 (en) | Human sulfatases | |
WO1998045442A3 (en) | Secreted f-spondin homologs | |
WO1999067384A3 (en) | Prostate cancer-associated genes | |
AU3365499A (en) | Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof | |
EP0939124A3 (en) | MGBP1 sequences | |
WO2000029448A3 (en) | Human proteins having hydrophobic domains and dnas encoding these proteins | |
WO1998057983A3 (en) | Mammalian neuro-growth factor like protein | |
WO1997029199A3 (en) | Prostate specific antigen peptides and uses thereof | |
WO2001094418A3 (en) | Leader peptides for enhancing secretion of recombinant protein from a host cell | |
CA2204151A1 (en) | Cdna encoding a bmp type ii receptor | |
EP1443055A3 (en) | Interleukins-21 and 22 | |
DE69832484D1 (en) | Phosphatidyl-3,4,5-triphosphat abhängige proteinkinase | |
WO1999031128A3 (en) | Human tumor necrosis factor-r2-like proteins | |
WO2000018909A3 (en) | NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998543125 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |